Neos Therapeutics, Inc
NEOS
NEOS was delisted on the 19th of March, 2021.
52 hedge funds and large institutions have $30.4M invested in Neos Therapeutics, Inc in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
29% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 14
8% more funds holding
Funds holding: 48 → 52 (+4)
15% less capital invested
Capital invested by funds: $35.9M → $30.4M (-$5.51M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$2.3M |
| 2 |
CCI
Columbus Circle Investors
|
+$286K |
| 3 |
Morgan Stanley
New York
|
+$246K |
| 4 |
State Street
Boston,
Massachusetts
|
+$244K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$232K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$2.23M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.19M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.13M |
| 4 |
WSA
Wall Street Associates
Lajolla,
California
|
-$983K |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$670K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $3K | – | – | – |
|
|
WSA
52
Wall Street Associates
Lajolla,
California
| – | -$983K | -149,343 | Closed |
|
53
Goldman Sachs
New York
| – | -$99K | -15,094 | Closed |
|
54
ProShare Advisors
Bethesda,
Maryland
| – | -$76K | -11,490 | Closed |
|
|
LTFS
55
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | -$10K | -1,537 | Closed |
|
56
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$149 | -22 | -48% |
|
NEOS Hedge Fund Activity: Q4 2016 in Review
52 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q4 2016, worth a combined $30.4M — down 15% from $35.9M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new NEOS positions and 4 closed out — a net gain of 4 holders — while 18 added to existing stakes and 14 trimmed.
The largest buyer was Northern Trust, adding an estimated $2.3M. The largest seller was Perceptive Advisors, cutting an estimated $2.23M.
- 52 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q4 2016, up from 48 in Q3 2016.
- Funds reported $30.4M of Neos Therapeutics, Inc stock for Q4 2016, down 15% quarter-over-quarter.
- 8 funds opened new Neos Therapeutics, Inc positions in Q4 2016 and 4 closed out, a net change of +4 holders.
- The largest Neos Therapeutics, Inc buyer in Q4 2016 was Northern Trust, an estimated $2.3M added.
- The largest Neos Therapeutics, Inc seller in Q4 2016 was Perceptive Advisors, an estimated $2.23M sold.
Based on aggregated 13F filings for Q4 2016.